Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G81971FM
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
Taxonomic Hierarchy
KEGG BRITE Database
- KEGG ID
Pathway
| Pathway Name | Organism |
|---|---|
| Lewis blood group biosynthesis | Bos taurus |
| Lewis blood group biosynthesis | Sus scrofa |
| Lewis blood group biosynthesis | Caenorhabditis elegans |
| Lewis blood group biosynthesis | Homo sapiens |
| Lewis blood group biosynthesis | Dictyostelium discoideum |
| Lewis blood group biosynthesis | Drosophila melanogaster |
| Lewis blood group biosynthesis | Canis familiaris |
| Lewis blood group biosynthesis | Xenopus tropicalis |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dglc-HEX-1:5 2s:n-acetyl 3b:b-dgal-HEX-1:5 4b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 5s:n-acetyl 6b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3o(3+2)4d 4:4d(5+1)5n 5:1o(4+1)6d
- WURCS
- WURCS=2.0/4,4,3/[a2122h-1x_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O][a1221m-1a_1-5]/1-2-3-4/a3-b1_a4-d1_b3-c2
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38170408 | Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study | Doppenberg D | 2024 Jan 03 |
|
| 38169384 | Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study | Li Z | 2024 Jan 02 |
|
| 38213206 | A Case of Pseudoelevation of Serum CA19-9 Level | Li G | 2024 Jan 01 |
|
| 38459847 | [Factors and Mechanisms of Pleural Dissemination in Surgically Treated Cases of Lung Metastasis Originated from Pancreatic Cancer] | Suzuki S | 2024 Jan |
|
| 37558203 | The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment | Hao YJ | 2024 Jan |
|
| 37980963 | Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (CEA and CA 19.9.) | Polette D | 2024 Jan |
|
| 37839499 | A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma | Xu C | 2024 Jan |
|
| 37714269 | Significant CA 19–9 elevation in IgG4-related autoimmune pancreatitis – A diagnostic dilemma | Farrukh L | 2024 Jan |
|
| 38416491 | Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma | Yousef A | 2024 Feb 28 |
|
| 38395994 | NLCECA score: a serum inflammatory-tumor biomarker score to predict survival of advanced perihilar cholangiocarcinoma after hepatic arterial infusion chemotherapy | Fu S | 2024 Feb 23 |
|
